Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Time trends of clinicopathologic features and surgical treatment for gastric cancer: Results from 2 high-volume institutions in southern China.

Wang W, Zheng C, Fang C, Li P, Xie J, Lin J, Zhan Y, Li W, Chen Y, Sun X, Xu D, Li Y, Huang C, Zhou Z.

Surgery. 2015 Dec;158(6):1590-7. doi: 10.1016/j.surg.2015.04.038. Epub 2015 Jul 23.

PMID:
26210225
2.

[Current status of surgical treatment of gastric gastrointestinal tumors: a national multi-center retrospective study].

Feng X, Li R, Zhang P, Chen T, Qiu H, Zhou Y, Du C, Yin X, Pan F, Zheng G, Sun X, Yu J, Chen Z, Zhao Y, Liu X, Li J, Zhang B, Zhou Y, Huang C, Zhou Z, Li G, Tao K, Li Y.

Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Nov 25;19(11):1258-1264. Chinese.

PMID:
27928796
3.

Surgical outcomes for gastric cancer of a single institute in southeast China.

Ding YB, Xia TS, Wu JD, Chen GY, Wang S, Xia JG.

Am J Surg. 2012 Feb;203(2):217-21. doi: 10.1016/j.amjsurg.2010.10.022. Epub 2011 Jul 30.

PMID:
21803328
4.

[Changes in clinicopathological features and survival after surgical resection for gastric cancer over a 20-year period at a single institution].

Wang W, Zhou Z, Zhan Y, Li W, Chen Y, Sun X, Xu D, Li Y, Guan Y, Yuan S, Qiu H, Chen Y, Liu Z, Liang Y.

Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Feb;17(2):139-44. Chinese.

PMID:
24577768
5.

Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus.

Zhang YF, Shi J, Yu HP, Feng AN, Fan XS, Lauwers GY, Mashimo H, Gold JS, Chen G, Huang Q.

World J Gastroenterol. 2012 Jul 21;18(27):3602-9. doi: 10.3748/wjg.v18.i27.3602.

6.

Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.

Chen H, Shen DP, Zhang ZZ, Liu JH, Shen YY, Ni XZ.

World J Gastroenterol. 2015 Feb 14;21(6):1838-44. doi: 10.3748/wjg.v21.i6.1838.

7.

Strategies to improve treatment outcome in gastric cancer: a retrospective analysis of patients from two high-volume hospitals in Korea and China.

Yang K, Choi YY, Zhang WH, Chen XZ, Song MK, Lee J, Zhang B, Chen ZX, Kim HI, Chen JP, Cheong JH, Zhou ZG, Hyung WJ, Hu JK, Noh SH.

Oncotarget. 2016 Jul 12;7(28):44660-44675. doi: 10.18632/oncotarget.9378.

8.

Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.

Kim DH, Kim SM, Hyun JK, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S.

Ann Surg Oncol. 2013 Jul;20(7):2317-27. doi: 10.1245/s10434-012-2700-0. Epub 2013 May 16. Erratum in: Ann Surg Oncol. 2014 Dec;21 Suppl 4:S782.

PMID:
23677605
9.

[The significance of No.13 lymph node dissection in D2 gastrectomy for lower-third advanced gastric cancer].

Jiao XG, Liang H, Deng JY, Wang L, Liu HG, Liang YX.

Zhonghua Wai Ke Za Zhi. 2013 Mar;51(3):235-9. Chinese.

PMID:
23859325
10.

Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.

Park YD, Chung YJ, Chung HY, Yu W, Bae HI, Jeon SW, Cho CM, Tak WY, Kweon YO.

Endoscopy. 2008 Jan;40(1):7-10. doi: 10.1055/s-2007-966750.

PMID:
18210339
11.

The relationship between improved prognosis in gastric cancer patients in the last 25 years and changing methods of surgical and combined treatment.

Popiela T, Kulig J, Kołodziejczyk P; Polish Gastric Cancer Study Group.

Przegl Lek. 2000;57 Suppl 5:9-13.

PMID:
11202309
12.

Clinicopathological features and trend changes of gastric carcinoma in Southern China.

Peng JJ, Xiao P, Xu JB, Song W, Liao B, He YL.

World J Gastroenterol. 2014 Apr 21;20(15):4401-6. doi: 10.3748/wjg.v20.i15.4401.

13.

Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years.

Liang YX, Deng JY, Guo HH, Ding XW, Wang XN, Wang BG, Zhang L, Liang H.

World J Gastroenterol. 2013 Oct 21;19(39):6568-78. doi: 10.3748/wjg.v19.i39.6568.

14.

Re-study of gastric cancer: analysis of outcome.

Samson PS, Escovidal LA, Yrastorza SG, Veneracion RG, Nerves MY.

World J Surg. 2002 Apr;26(4):428-33. Epub 2002 Feb 4.

PMID:
11910474
15.

[Therapeutic effects of transabdominal radical total gastrectomy on cardiac cancer: analysis of 56 cases].

Wu T, Wan YL, Rong L, Pan YS, Wang X, Liu YC.

Zhonghua Yi Xue Za Zhi. 2007 Jun 5;87(21):1474-7. Chinese.

PMID:
17785085
16.

Lymphadenectomy in patients with gastric cancer. A critical review.

Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Farinati F, Belluco C, Lise M.

Suppl Tumori. 2003 Sep-Oct;2(5):S35-8.

PMID:
12914388
17.

Prognosis of 980 patients with gastric cancer after surgical resection.

Wang W, Li YF, Sun XW, Chen YB, Li W, Xu DZ, Guan XX, Huang CY, Zhan YQ, Zhou ZW.

Chin J Cancer. 2010 Nov;29(11):923-30.

18.

Resectable gastric cancer: operative mortality and survival analysis.

Wang CS, Hsieh CC, Chao TC, Jan YY, Jeng LB, Hwang TL, Chen MF, Chen PC, Chen JS, Hsueh S.

Chang Gung Med J. 2002 Apr;25(4):216-27.

19.

[Prognostic analysis of liver metastasis in gastric cancer patients with radical gastrectomy].

Deng JY, Liang H, Liu N, Zhang RP, Zhan HJ, Wang XJ, Hao XS.

Zhonghua Wei Chang Wai Ke Za Zhi. 2008 Mar;11(2):145-9. Chinese.

PMID:
18344082
20.

Total gastrectomy for gastric cancer: an analysis of postoperative and long-term outcomes through time: results of 413 consecutive cases in a single cancer center.

da Costa WL Jr, Coimbra FJ, Ribeiro HS, Diniz AL, de Godoy AL, de Farias IC, Begnami MD, Soares FA.

Ann Surg Oncol. 2015 Mar;22(3):750-7. doi: 10.1245/s10434-014-4212-6. Epub 2014 Oct 31.

PMID:
25366586

Supplemental Content

Support Center